These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15799361)

  • 1. [Secondary amyloidosis associated with rheumatoid arthritis (RA)].
    Koseki Y; Goto M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():278-82. PubMed ID: 15799361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary amyloidosis in patients with rheumatoid arthritis].
    Yasuda M
    Nihon Rinsho; 2005 May; 63 Suppl 5():386-90. PubMed ID: 15954381
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
    Smith GR; Tymms KE; Falk M
    Intern Med J; 2004; 34(9-10):570-2. PubMed ID: 15482271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of etanercept in amyloidosis secondary to rheumatoid arthritis, a report of two cases].
    Macías Fernández I; Fernández Rodríguez AM; García Pérez S
    Reumatol Clin; 2011; 7(6):397-400. PubMed ID: 22078699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary amyloidosis in patients with rheumatoid arthritis(RA)].
    Inada S
    Nihon Rinsho; 2002 Dec; 60(12):2417-22. PubMed ID: 12510371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
    J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
    Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
    Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T
    Mod Rheumatol; 2008; 18(2):109-18. PubMed ID: 18369528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
    Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor inactivation in the management of rheumatoid arthritis.
    Baumgartner SW
    South Med J; 2000 Aug; 93(8):753-9. PubMed ID: 10963503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor necrosis factor inhibitors in patients with RA.
    Trethewey P
    JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective.
    Nobre CA; Callado MR; Rodrigues CE; de Menezes DB; Vieira WP
    Rev Bras Reumatol; 2010; 50(2):205-10. PubMed ID: 21125155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic therapy for rheumatoid arthritis.
    Klippel JH
    N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
    [No Abstract]   [Full Text] [Related]  

  • 14. [TNF antagonists in therapy of rheumatoid arthritis].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
    [No Abstract]   [Full Text] [Related]  

  • 15. [Amyloidosis in patients with rheumatoid arthritis].
    Bluszcz-Roznowska A; Kucharz EJ
    Przegl Lek; 2005; 62(12):1532-7. PubMed ID: 16786790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological first-choice preparations in Region H].
    Graudal N; Jacobsen S; Baslund B; Jürgens G
    Ugeskr Laeger; 2010 Nov; 172(45):3127. PubMed ID: 21105207
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D; La Montagna G
    Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
    [No Abstract]   [Full Text] [Related]  

  • 18. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract]   [Full Text] [Related]  

  • 19. [The rheumatologists' conflict of interest and biological medicines].
    Gøtzsche PC; Lundh A
    Ugeskr Laeger; 2010 Nov; 172(45):3126; author reply 3126. PubMed ID: 21105206
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?
    O'Dell JR
    N Engl J Med; 1999 Jan; 340(4):310-2. PubMed ID: 9920958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.